Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Xolair approved in Europe for chronic spontaneous urticaria

March 7, 2014

Investigators prepare novel nanovesicles to stimulate healing

Feb. 28, 2014

Anacor Pharmaceuticals completes end-of-phase II meeting with the FDA for AN-2728

Feb. 28, 2014

European approval for Mirvaso for facial erythema of rosacea

Feb. 26, 2014

Cellceutix submits IND for Prurisol trial, begins enrollment in phase IIb trials of brilacidin

Feb. 20, 2014

French group discloses novel CYP26A1 inhibitors for dermatological disorders

Feb. 19, 2014

Novel Ca(v)3.2. blockers disclosed by Kyowa Hakko Kirin

Feb. 17, 2014

Dermira provides progress update for three programs

Feb. 13, 2014

Nestle acquires L'Oreal's stake in Galderma and launches Nestle Skin Health

Feb. 12, 2014

Valeant Pharmaceuticals to acquire PreCision Dermatology

Feb. 5, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...